Blog Archives

Trajan Named in Top 20 “Businesses of Tomorrow” List

Screen Shot 2017-04-12 at 3.50.55 pmTrajan Scientific and Medical (Trajan) has been named one of the top 20 leading “Businesses of Tomorrow” in Australia.

Commissioned by Westpac and conducted by Deloitte, the Businesses of Tomorrow study identified companies that are shaping Australia’s future. Judging criteria included: track record of delivery, ability to meet future challenges and contribution to the community, industry or economy.

Trajan‘s strong collaborative relationship with researchers, such as IPAS within the University of Adelaide, allowing the company to be at the forefront of innovation, was a contributing factor in gaining a place in the top 20 list.  Furthermore, Trajan’s evolution from an engineering business to market-focused company allows Trajan to “remain agile and adaptable to market needs”.

A branch of Trajan has been colocated with IPAS since September 2016, following the Photonics Catalyst Program, a joint initiative between the South Australian government and IPAS to connect industry with research.

A full report on the top 200 Australian Businesses of Tomorrow can be found here.

Finalist for the 2016 South Australian Science Excellence Award – Excellence in Research Collaboration UoA and Trajan

Photo: Tom Roschi

Photo: Tom Roschi

IPAS along with Trajan have been named finalist for Excellence in Research Collaboration award by the Government of South Australia.

From the Government of South Australia, Department of State Development:
The Science Excellence Awards is South Australia’s premier event to recognise and reward outstanding scientific endeavour, including its application in industry and the advancement of science and mathematics education.

Finalist for the 2016 South Australian Science Excellence Award – Excellence in Research Collaboration:

Trajan – University of Adelaide partnership
In November 2015, the University of Adelaide (UoA) commenced a major strategic partnership with Trajan Scientific and Medical (Trajan), with the support of the South Australian government, and launched the new Trajan R&D and Manufacturing Hub in Adelaide at the University. This collaboration is enabling the realisation of research, development and commercialisation of new generation specialty glass products for the global science and medical equipment market.

The winner will be announced at the SA Science Excellence Awards Ceremony on Friday 12 August 2016.

Photo: Tom Roschi

Photo: Tom Roschi

Photo: Tom Roschi

Photo: Tom Roschi

Photo: Tom Roschi

Photo: Tom Roschi

Photo: Tom Roschi

Photo: Tom Roschi

Magnify your impact – BioNews Article

Magnify your Impact BioNews ArticleThe IPAS / Trajan Scientific and Medical collaboration has been featured in the latest edition of BioSA News for May 2016 in an article titled ‘Magnify your Impact’. Prof Heike Ebendorff-Heidepriem has also been featured on the front cover of the article.

“Adelaide will become home to a new research and advanced manufacturing hub following a strategic collaboration between global medical technology development company, Trajan Scientific and Medical, and the University of Adelaide’s Institute for Photonics and Advanced Sensing (IPAS).

The Hub will be based on the advances in the production of specialty glass fibres crucial in developing the next generation of chemical and biological sensors, and high-precision instruments.”

Read the full article here

Link to the BioNews May 2016 Full Edition

BioNews May 2016

Trajan’s partnership with IPAS announced in Parliament

Hi-tech medical instruments hub up and running

Anne Collins - Trajan Scientific and Medical

Dr Anne Collins General Manager of the Instruments, Sensors and Devices Business Unit

A CUTTING edge hub to produce world class medical and science lab instruments has begun developing its first commercial products.

The centre opened in South Australia in late November and is already assuming global responsibility for commercially producing the hemaPEN – a device for dried blood spot sampling.

The collaboration between the University of Adelaide and Trajan Scientific and Medical (Trajan) is supported by the South Australian government.

What we want to do out of Adelaide is create the next generation of analytical equipment

Trajan has a long history in precision glass manufacturing while the University of Adelaide’s Institute for Photonics and Advanced Sensing is a world leader in specialised glass manufacture.

Instruments, Sensors and Devices Business Unit General Manager Anne Collins said the hemaPEN would have potential applications for diabetes and DNA testing but would be one of many specialised items brought to commercial reality at the hub.

She said the business unit would focus on taking hi-tech products from their infancy and turning them into something “you can pick up and use”.

“Just about any lab you go into in the world will have analytical equipment that contains Trajan’s products,” Dr Collins said.

“What we want to do out of Adelaide is create the next generation of analytical equipment.

“Some of the objectives we’ve got are to take technologies, make them more applicable and get them into more places and make them smaller and more affordable.”

Dr Collins said many of the instruments would leverage the core technology and glass expertise from the University’s Institute for Photonics and Advanced Sensing.

“What’s great about being physically located here is that we’re interfacing on a daily basis with the researchers in IPAS. My door’s been open for less than three weeks and the number of people coming in with ideas is just phenomenal and that’s the advantage of being specifically located within the university.”

Trajan CEO Stephen Tomisich said the hub was an important milestone in the company’s journey as it expanded from its historical manufacturing hub in Melbourne, Victoria.

“The combination of the location in Adelaide, the collaboration with IPAS and the university, and the expansion of technical capabilities puts us in a strong position to realize our vision of enriching wellbeing,” he said.

He added that the Australian government’s recently released Innovation Statement that will help fund research and development will help more businesses collaborate with universities.

“We believe the renewed focus on science and innovation and the long term sustainable benefits to the economy are well directed,” Tomisich said.  “This is a first big step in the right direction.”

The strategic partnership grew from the Photonics Catalyst Program – a joint initiative between the South Australian government and IPAS to build connections between industry and emerging laser and sensing technologies.

Key to the partnership is the presence of the Optofab Node of the Australian National Fabrication Facility at the University and Health Industries South Australia.

University of Adelaide Adelaide’s Institute for Photonics and Advanced Sensing includes 205 researchers, about 20 of whom will be directly involved with Trajan.

IPAS manager Piers Lincoln said having the highest level of industry collaboration in the same building as an advanced manufacturer such as Trajan was invaluable.

“We work with a lot of companies in other areas such as the wine industry and mining services and they might need a tiny part like a widget made so rather than searching overseas Trajan fills that gap perfectly,” he said.

“We are so excited about having Trajan here and what it represents.”

Article from “The Lead”

Trajan welcomes Australian Prime Minister to showcase its ‘disruptive innovation’ with academia and start-ups

Mr Michael Sukkar, MP, Member for Deakin, the Hon. Malcolm Turnbull, MP, Prime Minister of Australia, Mr Stephen Tomisich, Chief Executive Officer, Trajan Scientific and Medical

Mr Michael Sukkar, MP, Member for Deakin, the Hon. Malcolm Turnbull, MP, Prime Minister of Australia, Mr Stephen Tomisich, Chief Executive Officer, Trajan Scientific and Medical

Trajan Scientific and Medical (Trajan) has highlighted to Australia’s Prime Minister Malcolm Turnbull that “disruptive innovation” is well underway locally and globally, welcoming him to the company’s Global Headquarters in Melbourne, Australia, to showcase Trajan’s pioneering partnerships with academia and start-ups that are set to become a critical new pillar of the Australian economy.

Chief Executive Officer of Trajan, Stephen Tomisich comments: “Trajan identified the vital role of collaboration with other sectors, including academia and start-ups, some time ago. To have the Prime Minister here shows his genuine interest in, and alignment with, what we are already doing. We are enthused and excited by the Government’s refreshed recognition of the importance of innovation within the context of collaboration to the nation’s prosperity.”

The Prime Minister’s visit comes as the Government announces three pillars to its innovation agenda, with the third pillar changing the way universities and academics are funded, making part of their funding dependent on engaging with industry and successfully creating start-ups from their research.

Mr Tomisich continues: “Rolling out new models to fund and nurture innovative start-ups, taking those brilliant concepts and ideas nestled in the labs and lecture halls of universities – Trajan identifies these opportunities and in doing so, essentially creates new IP-based, successful and sustainable ideas and enterprises that can deliver long-term economic benefit.”

During the visit, discussions covered Trajan’s fresh take on partnering with academia, including the University of Tasmania and The University of Adelaide, demonstrating true “disruptive innovation”, proving many of the Government’s longer term goals around collaboration and support of start-ups are already underway.

Trajan’s strategic collaboration with the University of Adelaide, supported by the South Australian Government, was announced in September 2015 and sees the realisation of a research and development and manufacturing hub based on a new generation of specialty glass products for the global science and medical equipment market.

The hub will help scientists in the University’s Institute for Photonics and Advanced Sensing (IPAS) and the School of Physical Sciences commercialize their research into products that ultimately benefit human health and wellbeing, and the products have the potential to be utilized in a wide range of medical and scientific applications including genetic testing, biomarker discovery and detection, environmental analysis, food safety testing, testing for drugs of abuse and therapeutic drug monitoring.

In 2013 an innovative collaboration between the University of Tasmania, Trajan and the Federal Government was announced, and saw the creation of the $5.2 million Australian Research Council (ARC) Training Centre for Portable Analytical Separation Technologies (ASTech) at the University. The Researchers are driving at revolutionary new technologies which could see complex medical and industrial testing brought out of the lab and onto a smartphone. The prospect of ‘miniaturizing’ analytical separation technologies – now conducted in large, specialized laboratories – could also produce huge efficiencies in time and logistics.

Bridging the gap between the academic world and real life is a major focus for Trajan, whose focus is on developing and commercializing technologies that enable analytical systems to be more selective, sensitive and specific for biological, environmental or food related measurements – especially those that can lead to portability, miniaturization and affordability.

Mr Michael Sukkar, Federal Member for Deakin, Victoria commented he was proud to have a business like Trajan in his electorate: “Energizing the growth and productivity of local business and enterprise in Deakin is important. Trajan’s business model, which is centred on supporting start-up companies and with its focus on collaboration, there is a very bright future for local innovation, research and development, manufacturing and industry.”

Mr Tomisich concludes it is an honour to be able to share Trajan’s story with the Prime Minister: “Trajan’s vision is that through science interfacing with society, we can impact the wellbeing of a growing number of communities globally. We are committed to helping the Prime Minister understand more about how Trajan’s collaborative model and technology direction is reflected in the Australian Government’s plans to support growth of the scientific industry here and overseas.”

Article featured on the Trajan Website

Mr Michael Sukkar, MP, Member for Deakin, the Hon. Malcolm Turnbull, MP, Prime Minister of Australia, Mr Stephen Tomisich, Chief Executive Officer, Trajan Scientific and Medical, Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical

Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical, Mr Michael Sukkar, MP, Member for Deakin, Mr Stephen Tomisich, Chief Executive Officer, Trajan Scientific and Medical, the Hon. Malcolm Turnbull, MP, Prime Minister of Australia

Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical, Mr Michael Sukkar, MP, Member for Deakin, Mr Stephen Tomisich, Chief Executive Officer, Trajan Scientific and Medical, the Hon. Malcolm Turnbull, MP, Prime Minister of Australia